OBJECTIVE: Labor course analysis during induction of labor (IOL) often focuses on time elapsed. Oxytocin titration is a continuous variable critical for vaginal delivery (VD). The national goal VD rate is between 75-90%; VD rate during IOL is lower among obese vs normal weight women. We hypothesized the maximum oxytocin dose (oxy max ) reached during IOL would affect the probability of VD differentially by maternal BMI. STUDY DESIGN: A secondary analysis of the Consortium on Safe Labor including 1,443 term, singleton, nulliparous women with unfavorable cervix undergoing IOL. As not all women undergo VD, their labor course prior to cesarean delivery (CD) was observed to estimate the oxy max needed to achieve VD during IOL. Survival analysis methodology was used to assess probability of VD by oxy max in all women undergoing IOL, including partial data for women censored due to CD. Kaplan Meier (KM) curves were compared using a log-rank test for 5 BMI (kg/m 2 ) categories: normal (18.5-24.9), overweight (25.0-29.9), obese I (30.0-34.9), obese II (35.0-39.9) and obese III (40.0). A Cox proportional-hazards model was fit to compare oxy max necessary to achieve VD and adjusted for variables associated with increased oxy max dose. RESULTS: In all BMI groups, more VDs occur as oxy max increased ( Figure 1a ) and the final cumulative VD rates differ by BMI: normal 91%, overweight 81%, obese I 68%, obese II 58% and obese III 47% (p<0.001). Only normal and overweight women achieved a VD rate of > 75%. BMI is significantly associated with oxy max needed to achieve VD on KM analysis (Figure 1b) . When accounting for censoring by CD, the oxy max corresponding to achieving a VD rate of 75% differed by BMI: normal and overweight at 20 mu/min, obese I at 24 mu/min, obese II at 28 mu/min, and obese III at 36 mu/min (p<0.001). In the multivariable model, BMI and magnesium were significantly associated with a higher oxy max to achieve VD (Table 1) . Obese III vs normal weight women were 59% less likely to have VD at any oxytocin dose [HR 0.41 (0.3-0.6) p<0.001]. CONCLUSION: Among BMI groups, there were significant differences in the oxy max needed to achieve a VD rate >75%. High BMI women are less likely to have a VD at 20 mu/min. Future work should examine other outcomes associated with higher oxytocin dose regimens, but this approach may represent one lever to safely reduce CDs among patients with a lower chance of achieving a VD. OBJECTIVE: A pregnancy at risk of delivery in the periviable period presents a clinical and ethical challenge, requiring in-depth counseling and complex decision-making. While it is generally known that cesarean delivery (CD) increases maternal morbidity compared to vaginal delivery (VD), there is limited information regarding the implications of periviable mode of delivery on subsequent pregnancy outcomes. Our study assesses whether women who undergo a periviable CD (index CD) have increased rates of severe maternal morbidity in subsequent pregnancies as compared to those with a prior periviable VD (index VD). STUDY DESIGN: This is a retrospective cohort study of all pregnant women who had live born deliveries between 22-26 weeks gestation and a subsequent pregnancy during 2004-2016 at a single tertiary care center. Maternal and neonatal demographic information for both the index periviable and subsequent pregnancies were collected and analyzed using chi-square and t-test statistics. The primary outcome was a composite of severe maternal morbidity, including uterine complications, ICU admission, sepsis, venous thromboembolism and transfusion. Secondary maternal obstetric complications and neonatal morbidity parameters were also analyzed. Multivariable logistic regression modeling was performed to determine the impact of index mode of delivery on composite maternal and neonatal morbidity outcomes. RESULTS: One hundred and thirty-four women and 161 neonates met inclusion criteria. Maternal and neonatal demographics of the index VD (n¼60) versus index CD (n¼74) groups were similar.
OBJECTIVE: Labor course analysis during induction of labor (IOL) often focuses on time elapsed. Oxytocin titration is a continuous variable critical for vaginal delivery (VD). The national goal VD rate is between 75-90%; VD rate during IOL is lower among obese vs normal weight women. We hypothesized the maximum oxytocin dose (oxy max ) reached during IOL would affect the probability of VD differentially by maternal BMI. STUDY DESIGN: A secondary analysis of the Consortium on Safe Labor including 1,443 term, singleton, nulliparous women with unfavorable cervix undergoing IOL. As not all women undergo VD, their labor course prior to cesarean delivery (CD) was observed to estimate the oxy max needed to achieve VD during IOL. Survival analysis methodology was used to assess probability of VD by oxy max in all women undergoing IOL, including partial data for women censored due to CD. Kaplan Meier (KM) curves were compared using a log-rank test for 5 BMI (kg/m 2 ) categories: normal (18.5-24.9), overweight (25.0-29.9), obese I (30.0-34.9), obese II (35.0-39.9) and obese III (40.0). A Cox proportional-hazards model was fit to compare oxy max necessary to achieve VD and adjusted for variables associated with increased oxy max dose. RESULTS: In all BMI groups, more VDs occur as oxy max increased ( Figure 1a ) and the final cumulative VD rates differ by BMI: normal 91%, overweight 81%, obese I 68%, obese II 58% and obese III 47% (p<0.001). Only normal and overweight women achieved a VD rate of > 75%. BMI is significantly associated with oxy max needed to achieve VD on KM analysis (Figure 1b) . When accounting for censoring by CD, the oxy max corresponding to achieving a VD rate of 75% differed by BMI: normal and overweight at 20 mu/min, obese I at 24 mu/min, obese II at 28 mu/min, and obese III at 36 mu/min (p<0.001). In the multivariable model, BMI and magnesium were significantly associated with a higher oxy max to achieve VD (Table 1) . Obese III vs normal weight women were 59% less likely to have VD at any oxytocin dose [HR 0.41 (0.3-0.6) p<0.001]. CONCLUSION: Among BMI groups, there were significant differences in the oxy max needed to achieve a VD rate >75%. High BMI women are less likely to have a VD at 20 mu/min. Future work should examine other outcomes associated with higher oxytocin dose regimens, but this approach may represent one lever to safely reduce CDs among patients with a lower chance of achieving a VD. OBJECTIVE: A pregnancy at risk of delivery in the periviable period presents a clinical and ethical challenge, requiring in-depth counseling and complex decision-making. While it is generally known that cesarean delivery (CD) increases maternal morbidity compared to vaginal delivery (VD), there is limited information regarding the implications of periviable mode of delivery on subsequent pregnancy outcomes. Our study assesses whether women who undergo a periviable CD (index CD) have increased rates of severe maternal morbidity in subsequent pregnancies as compared to those with a prior periviable VD (index VD). STUDY DESIGN: This is a retrospective cohort study of all pregnant women who had live born deliveries between 22-26 weeks gestation and a subsequent pregnancy during 2004-2016 at a single tertiary care center. Maternal and neonatal demographic information for both the index periviable and subsequent pregnancies were collected and analyzed using chi-square and t-test statistics. The primary outcome was a composite of severe maternal morbidity, including uterine complications, ICU admission, sepsis, venous thromboembolism and transfusion. Secondary maternal obstetric complications and neonatal morbidity parameters were also analyzed. Multivariable logistic regression modeling was performed to determine the impact of index mode of delivery on composite maternal and neonatal morbidity outcomes. RESULTS: One hundred and thirty-four women and 161 neonates met inclusion criteria. Maternal and neonatal demographics of the index VD (n¼60) versus index CD (n¼74) groups were similar. There was no statistically significant difference in the maternal
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